Various ethical concerns that are essential elements in the critical trial of any new treatment modality are examined. Problems surrounding the issue of informed consent are considered. Conflicts between therapeutic and research considerations are discussed. The role of double-blind studies is examined.<
Published in:
Engineering in Medicine and Biology Magazine, IEEE
(Volume:7
,
Issue:
2
)
Date of Publication: June 1988